DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Curosurf (Poractant Alfa) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Curosurf (Poractant Alfa) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Curosurf side effects in female

Reported by a physician from China on 2012-01-04

Patient: female

Reactions: Dyspnoea, Pallor, Oxygen Saturation Decreased, Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Curosurf
    Dosage: daily dose 120 milligrams;unknown
    Indication: Neonatal Respiratory Distress Syndrome Prophylaxis
    Start date: 2011-11-07
    End date: 2011-11-07

Curosurf
    Dosage: daily dose 120 milligrams;unknown
    Indication: Oxygen Saturation Abnormal
    Start date: 2011-11-07
    End date: 2011-11-07

Other drugs received by patient: Mezlocillin (Mezlocillin); Etamsilate (Etamsilate); Cefotiam (Cefotiam); Oxygen (Oxygen); Ambroxol (Ambroxol)



Possible Curosurf side effects in male

Reported by a physician from China on 2012-01-04

Patient: male

Reactions: Peripheral Coldness, Dyspnoea, Rales, Erythema, Pallor, Poor Peripheral Circulation, Sepsis, Oxygen Saturation Decreased, Shock, Infantile Apnoeic Attack

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Curosurf

Other drugs received by patient: Etamsilate (Etamsilate); Cefotiam (Cefotiam); Mezlocillin (Mezlocillin); Ambroxol (Ambroxol)

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017